Showing results (161-170 of 409) with videos related to

Sort By:
Pageof 41
Developmental Neuropsychology|September 6, 2017
Maturational Trajectory of Processing Speed Performance in Pediatric Multiple SclerosisNadine Akbar, Alessio Signori, Maria Pia Amato, et al.
Neurology|September 28, 2018
Incidence and prevalence of MS in children: A population-based study in Ontario, CanadaRuth Ann Marrie, Julia O'Mahony, Colleen Maxwell, et al.
Neurology|January 11, 2020
Increased mental health care use by mothers of children with multiple sclerosisRuth Ann Marrie, Julia O'Mahony, Colleen Maxwell, et al.
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|August 11, 2017
7T MRI Visualization of Cortical Lesions in Adolescents and Young Adults with Pediatric-Onset Multiple SclerosisRitobrato Datta, Varun Sethi, Sophia Ly, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 31, 2018
Pediatric-onset multiple sclerosis is associated with reduced parental health-related quality of life and family functioningJulia O'Mahony, Ruth Ann Marrie, Audrey Laporte, et al.
Human Mutation|August 9, 2005
Gaucher mutation N188S is associated with myoclonic epilepsyLaurence Kowarz, Ozlem Goker-Alpan, Sharmila Banerjee-Basu, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 30, 2020
Assessment of plasma lyso-Gb3 for clinical monitoring of treatment response in migalastat-treated patients with Fabry diseaseDaniel G Bichet, Johannes M Aerts, Christiane Auray-Blais, et al.
Kidney International|December 22, 2016
Screening, diagnosis, and management of patients with Fabry disease: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies ConferenceRaphael Schiffmann, Derralynn A Hughes, Gabor E Linthorst, et al.
Plos One|December 18, 2009
Eukaryotic initiation factor 2B (eIF2B) GEF activity as a diagnostic tool for EIF2B-related disordersLaetitia Horzinski, Aurélia Huyghe, Marie-Céleste Cardoso, et al.
JIMD Reports|November 6, 2023
Comparison of efficacy between subcutaneous and intravenous application of moss-aGal in the mouse model of Fabry diseasePaulina Dabrowska-Schlepp, Andreas Busch, Jin-Song Shen, et al.
Pageof 41